Doxapram Hydrochloride

盐酸多沙普仑

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDoxapram Hydrochloride
Drug Alias Name盐酸吗乙苯吡酮盐酸多沙普化盐酸吗啉吡咯酮DopramDocatone +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCentral nervous system stimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory InsufficiencyApnea
Global Approved IndicationsRespiratory Insufficiency
Approved Indications in ChinaRespiratory Insufficiency
Original Approved Country/TerritoryUnited States
Original Approved Date1965/06/23
Country/TerritoryBelgiumCanadaUnited States +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesUniversitaire Ziekenhuizen LeuvenHikma Pharmaceuticals PlcXi'An Libang Pharmaceutical Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsRespiratory InsufficiencyApnea
Inactive IndicationsN/A

Other Information

ATC CodeR07AB01
Related LinksWikipediaDrugBankKEGG